ALB and neoplasm: The combination of nanotechnology and conventional tumor therapy can not only enhance the properties of chemoradiotherapy drugs but also reduce the incidence of poisoning and other side effects.39,47–58 Regulatory authorities have authorized several therapeutic nanoparticle (NP) platforms, such as liposomes, albumin, and polymeric micelles, for cancer treatment.